Save time and money with
Med Tech Market Research

MedTech Business intelligence
supplied by GlobalData

Infectious diseases


PharmaPoint: Hepatitis C Virus - United States Drug Forecast and Market Analysis to 2022
PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis to 2022
PharmaPoint: Hepatitis C Virus - Germany Drug Forecast and Market Analysis to 2022
PharmaPoint: Hepatitis C Virus - Italy Drug Forecast and Market Analysis to 2022
PharmaPoint: Hepatitis C Virus - Spain Drug Forecast and Market Analysis to 2022
PharmaPoint: Hepatitis C Virus - United Kingdom Drug Forecast and Market Analysis to 2022
PharmaPoint: Hepatitis C Virus - Japan Drug Forecast and Market Analysis to 2022
PharmaPoint: Hepatitis C Virus - Brazil Drug Forecast and Market Analysis to 2022
PharmaPoint: Hepatitis C Virus - China Drug Forecast and Market Analysis to 2022
PharmaPoint: Dermatophytic Onychomycosis (DO) - US Drug Forecast and Market Analysis to 2022
PharmaPoint: Dermatophytic Onychomycosis (DO) - Current and Future Players
PharmaPoint: Meningococcal Vaccines - Current and Future Players
PharmaPoint: Meningococcal Vaccines - US Drug Forecast and Market Analysis to 2022
PharmaPoint: Meningococcal Vaccines - France Drug Forecast and Market Analysis to 2022
PharmaPoint: Meningococcal Vaccines - Germany Drug Forecast and Market Analysis to 2022
PharmaPoint: Meningococcal Vaccines - Italy Drug Forecast and Market Analysis to 2022
PharmaPoint: Meningococcal Vaccines - Spain Drug Forecast and Market Analysis to 2022
PharmaPoint: Meningococcal Vaccines - UK Drug Forecast and Market Analysis to 2022
PharmaPoint: Meningococcal Vaccines - Australia Drug Forecast and Market Analysis to 2022
PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022
Terbinafine (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022
Itraconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022
Fluconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022
Griseofulvin (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022
Ketoconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022
Efinaconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022
Tavaborole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022
TDT-067 (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022
Luliconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022
Albaconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022
Ciclopirox (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022
PharmaFocus: Market Access Strategies for Antibiotics Targeting Multidrug-Resistant Gram-Negative Bacteria

 

 

To top

 
 

To top